This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Market Preview: Beware Corporate Sellouts

Two big tech names, both blue chips, report after Tuesday's close: Intel (INTC - Get Report) and IBM (IBM - Get Report).

Wall Street is looking for earnings of $3.62 a share from Big Blue on revenue of $25.38 billion. Jefferies, which has a hold rating and a $225 price target on the stock, is in line with the consensus view.

"We believe IBM had a strong quarter from software along with System x and System z servers," the firm said. "We estimate that the Services business saw an okay quarter relative to its peers given a tough macro environment. We believe IBM's cloud products are becoming more prominent and will see growth in storage."

With its stock up nearly 14% in 2012 and a streak of eight upside surprises on the line, IBM investors are no doubt expecting a bit more.

As for Intel, expectations are down since the no. 1 chip maker's warning in early September. The average estimate of analysts polled by Thomson Reuters is for a profit of 49 cents a share in the quarter on revenue of $13.23 billion.

In an earnings preview for the semiconductor companies, BMO Capital said even the expectations for fourth-quarter guidance are probably below the published numbers for the group. Here's the firm take on Intel: "[A]lthough estimates have come in a fair bit, we would like to see GM [gross margin] reset for us to begin to get more constructive on the stock. Despite the steady downward revisions, we are still below the Street for 2013 at [earnings of] $2.10 vs. now $2.17." Also slated to open the books after the bell are Apollo Group (APOL), Cree (CREE), CSX Corp. (CSX), Intuitive Surgical (ISRG - Get Report), Sonic Corp. (SONC), and United Rentals (URI).

Intuitive Surgical's report bears watching after the company was upgraded to overweight at JPMorgan on Monday. The firm also lifted its December 2013 price target on the stock to $625, implying potential appreciation of 22% from Monday's close at $512.53. Share have gained 10.7% year-to-date.

"While there are clearly some headwinds to the Intuitive Surgical (ISRG) story, notably the recent dVP [daVinci procedure] decline and industry-wide European challenges, we find the risk/reward increasingly compelling, in light of the meaningful opportunities emerging in partial nephrectomy, cholecystectomy, colorectal surgery and other areas (thoracic, etc.) - which, collectively, should more than offset the dVP softness and drive upside to Street estimates for the next several years," JPMorgan said.
3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
GS $163.30 -1.70%
INTC $30.35 -0.85%
ISRG $618.85 -2.30%
IBM $144.17 -0.76%
KO $44.84 -0.30%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs